Bridgeway Capital Management’s KALA BIO KALA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-2
Closed -$242K – 1359
2022
Q1
$242K Buy
+2
New +$157K ﹤0.01% 1134
2020
Q1
– Sell
-2
Closed -$579K – 1319
2019
Q4
$579K Hold
2
– – 0.01% 916
2019
Q3
$597K Hold
2
– – 0.01% 876
2019
Q2
$880K Hold
2
– – 0.01% 778
2019
Q1
$1.14M Buy
2
+1
+100% +$533K 0.01% 713
2018
Q4
$416K Hold
1
– – 0.01% 1054
2018
Q3
$839K Buy
+1
New +$914K 0.01% 964

Other funds holding KALA

Bridgeway Capital Management's KALA Position: Q2 2022 in Review

Bridgeway Capital Management sold out of KALA BIO (KALA) in Q2 2022, closing a stake of 2 shares — an estimated $242K sold.

Bridgeway Capital Management first reported a position in KALA in Q3 2018 and held it in 7 quarters. The position peaked at $1.14M in Q1 2019. 25 funds tracked by Wall St. Rank hold KALA as of Q2 2022.

  • Bridgeway Capital Management reported no remaining KALA BIO position as of Q2 2022 after selling out during the quarter.
  • Bridgeway Capital Management sold 2 KALA BIO shares in Q2 2022, an estimated $242K.
  • Bridgeway Capital Management first reported a position in KALA BIO in Q3 2018 and held it in 7 quarters.
  • Bridgeway Capital Management's KALA BIO position peaked at $1.14M in Q1 2019.
  • 25 funds tracked by Wall St. Rank held KALA BIO as of Q2 2022.

Based on Bridgeway Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.